The 2 MDM2 SNPs we investigated in the present study have been found to modify cancer development23, 25, 28, 29, and our findings may provide some new evidence as to whether these 2 promoter variants of MDM2 affect recurrence risk among SCCOP patients. Here, MDM2 is linked to cancer.